Abstract
The COVID-19 pandemic triggered the execution of studies that aim to elucidate the pathophysiology of the disease, thus contributing to the progress in the development of more efficient therapeutic strategies. One of the main approaches to this process is the investigation of the identity of the cells that participate in the immune response in patients infected with SARS-CoV-2. One of the…